The appearance of pustular psoriasis during antitumor necrosis factor therapy

J Clin Rheumatol. 2006 Oct;12(5):262. doi: 10.1097/01.rhu.0000240045.16855.39.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • Female
  • Humans
  • Infliximab
  • Middle Aged
  • Psoriasis / chemically induced*
  • Psoriasis / pathology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab